Mucosal Vaccine Vectors: Replication-Competent Versus Replication-Deficient Poxviruses

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|19|2015-2023

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.19, 2007-07, pp. : 2015-2023

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors

By  

Current Gene Therapy, Vol. 5, Iss. 6, 2005-12 ,pp. : 655-667

Bentham Science Publishers

Access to resources Recommend Favorite

Environmental Risk Assessment of Replication Competent Viral Vectors Applied in Clinical Trials: Potential Effects of Inserted Sequences

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 395-412

Bentham Science Publishers

Access to resources Recommend Favorite

Intraperitoneal Oncolytic and Tumor Vaccination Therapy with Replication-Competent Recombinant Virus: The Herpes Paradigm

By  

Current Gene Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 113-125

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Administration Route on the Biodistribution and Shedding of Replication-Deficient HAdV-5: A Qualitative Modelling Approach

By  

Current Gene Therapy, Vol. 10, Iss. 2, 2010-04 ,pp. : 107-127

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Administration Route on the Biodistribution and Shedding of Replication-Deficient AAV2: A Qualitative Modelling Approach

By  

Current Gene Therapy, Vol. 10, Iss. 2, 2010-04 ,pp. : 91-106

Bentham Science Publishers

Access to resources Recommend Favorite